Compagnie Lombard Odier SCmA’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-29,992
| Closed | -$570K | – | 640 |
|
|
2019
Q1 | $570K | Hold |
29,992
| – | – | 0.02% | 184 |
|
|
2018
Q4 | $405K | Hold |
29,992
| – | – | 0.02% | 211 |
|
|
2018
Q3 | $333K | Buy |
+29,992
| New | +$333K | 0.01% | 235 |
|
|
2017
Q1 | – | Sell |
-26,000
| Closed | -$128K | – | 901 |
|
|
2016
Q4 | $128K | Hold |
26,000
| – | – | ﹤0.01% | 490 |
|
|
2016
Q3 | $129K | Buy |
26,000
+8,000
| +44% | +$39.7K | ﹤0.01% | 528 |
|
|
2016
Q2 | $92K | Hold |
18,000
| – | – | ﹤0.01% | 582 |
|
|
2016
Q1 | $103K | Hold |
18,000
| – | – | ﹤0.01% | 612 |
|
|
2015
Q4 | $187K | Buy |
18,000
+6,000
| +50% | +$62.3K | 0.01% | 479 |
|
|
2015
Q3 | $222K | Buy |
12,000
+1,000
| +9% | +$18.5K | 0.01% | 399 |
|
|
2015
Q2 | $214K | Buy |
11,000
+3,000
| +38% | +$58.4K | 0.01% | 425 |
|
|
2015
Q1 | $141K | Buy |
8,000
+2,000
| +33% | +$35.3K | 0.01% | 574 |
|
|
2014
Q4 | $96K | Buy |
6,000
+1,000
| +20% | +$16K | ﹤0.01% | 551 |
|
|
2014
Q3 | $63K | Hold |
5,000
| – | – | ﹤0.01% | 704 |
|
|
2014
Q2 | $78K | Hold |
5,000
| – | – | ﹤0.01% | 700 |
|
|
2014
Q1 | $66K | Buy |
+5,000
| New | +$66K | ﹤0.01% | 697 |
|